Details of the Drug

General Information of Drug (ID: DMXA5K0)

Drug Name

CPI-200

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT03953742) Study of CPI-200 in Patients With Advanced Tumors. U.S. National Institutes of Health.